Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma, Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00098631
What this trial is testing

Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Squamous Cell Carcinoma of the Hypopharynx+13 more
National Cancer Institute (NCI) 88
Large-scale testing (Phase 3)Looking for participantsNCT04437329
What this trial is testing

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 352
Testing effectiveness (Phase 2)Study completedNCT04509726
What this trial is testing

EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive Metastatic/Refractory Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xinqiao Hospital of Chongqing 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT05813626
What this trial is testing

Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 89
Not applicableUnknownNCT03539250
What this trial is testing

Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma

Who this might be right for
Injury; Temporal Region
Jiangxi Provincial Cancer Hospital 350
Large-scale testing (Phase 3)Active Not RecruitingNCT03306121
What this trial is testing

TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 322
Not applicableStudy completedNCT04491435
What this trial is testing

Saliva Substitute Mouthwash in NPC Survivors With Xerostomia: A Randomized Controlled Trial

Who this might be right for
Xerostomia, Hyposalivation, Saliva Substitute, Radiation-induced Toxicity, Nasopharyngeal Cancer
Universiti Kebangsaan Malaysia Medical Centre 94
Large-scale testing (Phase 3)Not Yet RecruitingNCT06900218
What this trial is testing

PD-1 Antibody Sintilimab Combined With Capecitabine as Adjuvant Therapy for High-Risk Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University 664
Large-scale testing (Phase 3)Looking for participantsNCT04944914
What this trial is testing

Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 188
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT03180476
What this trial is testing

Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sichuan Cancer Hospital and Research Institute 21
Testing effectiveness (Phase 2)Ended earlyNCT01230476
What this trial is testing

Induction and Concurrent Chemoradiotherapy With Cetuximab for Patients With Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
University of Malaya 3
Not applicableStudy completedNCT00899821
What this trial is testing

Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
NYU Langone Health
Not applicableUnknownNCT01237704
What this trial is testing

Dysphagia Rehabilitation for Nasopharyngeal Carcinoma Patients Post Radiotherapy

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapy
Chinese University of Hong Kong 160
Large-scale testing (Phase 3)Active Not RecruitingNCT06118333
What this trial is testing

A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 386
Testing effectiveness (Phase 2)UnknownNCT01821495
What this trial is testing

Study of DC-CIK to Treat NPC

Who this might be right for
Nasopharyngeal Carcinoma
Guangxi Medical University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04910347
What this trial is testing

Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Yonsei University 57
Large-scale testing (Phase 3)UnknownNCT02500940
What this trial is testing

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Taichung Veterans General Hospital 54
Not applicableLooking for participantsNCT06313450
What this trial is testing

De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRadiotherapy; ComplicationsIMMUNOTHERAPY
Sun Yat-sen University 112
Testing effectiveness (Phase 2)UnknownNCT01417390
What this trial is testing

Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
First People's Hospital of Foshan 80
Next Page